Search for: "Boehringer Ingelheim Pharmaceutical, Inc" Results 41 - 60 of 90
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Jul 2013, 9:29 am by Spencer Aronfeld
  Some of the other diabetes drugs being investigated include Bydureon and Onglyza, sold by Bristol-Myers Squibb; AstraZeneca and Victoza from Novo Nordisk; Tradjenta from Eli Lilly and Boehringer Ingelheim; and Nesina from Takeda. [read post]
2 May 2013, 10:30 am by Amanda Greenburg
On March 26, 2013, Plaintiff Lisa Mulhall filed a claim in the Illinois Southern District Court against the manufacturers of Pradaxa, Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim International GmbH, for causing her mother’s death. [read post]
31 Jan 2013, 12:57 pm by Steve McConnell
  The plaintiffs brought a product liability claim against Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
26 Dec 2012, 1:35 pm by Tom Lamb
A Look At The Events And The Evidence Leading Up To This Latest FDA Action Concerning The Safety Of Pradaxa  (Posted by Tom Lamb at DrugInjuryWatch.com) We set the stage with this December 19, 2012 drug company press release, "Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
10 Dec 2012, 2:50 pm by Tom Lamb
In the first part of December 2012 Boehringer Ingelheim Pharmaceuticals, Inc., the drug company responsible for Pradaxa, seems to be trying to assure doctors and patients that its relatively new, and certainly controversial, blood thinner medication is safe. [read post]
20 Nov 2012, 8:32 am by fraudfighters
This settlement was with pharmaceutical giant Boehrigner Ingelheim Pharmaceuticals Inc.  [read post]
9 Nov 2012, 2:15 pm by Tom Lamb
November 7, 2012:  "Interim Results from RELY-ABLE®, the RE-LY® Extension Study, Provide Additional Clinical Evidence for the Safety of Pradaxa® (dabigatran etexilate mesylate)"  (Drug company Press Release) @EXCERPT:  Boehringer Ingelheim Pharmaceuticals, Inc. today announced interim results from the RELY-ABLE® trial, a long-term extension of the RE-LY® study. [read post]
2 Nov 2012, 11:58 am by Bexis
Boehringer Ingelheim Pharmaceuticals, Inc., 2009 WL 702007, at *3-4 (D. [read post]
26 Oct 2012, 12:53 pm by Joe Consumer
s announcement of another big health care fraud settlement, specifically, Boehringer Ingelheim Pharmaceuticals Inc. will pay $95 million to settle allegations that the company promoted three drugs for uses that were not medically accepted.… Thursday's announcement is the latest in a series of settlements with pharmaceutical companies engaging in so-called off-label marketing. [read post]
26 Oct 2012, 4:31 am by Ben Vernia
According to DOJ’s press release: Connecticut-based Boehringer Ingelheim Pharmaceuticals Inc. has agreed to pay $95 million to resolve allegations relating to the improper promotion of the stroke-prevention drug Aggrenox, the chronic obstructive pulmonary disease (COPD) drugs Atrovent and Combivent, and the hypertension drug Micardis, the Justice Department announced today. [read post]
20 Aug 2012, 2:01 pm by Brenda Fulmer
These Pradaxa lawsuits were filed against Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation, and Boehringer Ingelheim Vetmedica, Inc.  [read post]
20 Aug 2012, 11:15 am by Tom Lamb
Since coming on the market in October 2010 the FDA has received numerous Adverse Event Reports involving: • Serious bleeding side effects • Hemorrhages such as hemorrhagic stroke In addition, some medical studies have associated Pradaxa with an increased risk: • Heart attack • Myocardial infarction (MI)• Acute coronary syndrome (ACS) Due to these serious side effects, a growing number of personal injury and wrongful death Pradaxa lawsuits have been filed against these defendants:… [read post]
25 Jul 2012, 9:03 pm
A man from Tennessee has filed a lawsuit against Boehringer Ingelheim Pharmaceuticals, Inc., the maker of Pradaxa. [read post]
25 Jul 2012, 4:03 pm by Leon Aussprung
A man from Tennessee has filed a lawsuit against Boehringer Ingelheim Pharmaceuticals, Inc., the maker of Pradaxa. [read post]
25 Jul 2012, 4:03 pm by Leon Aussprung
A man from Tennessee has filed a lawsuit against Boehringer Ingelheim Pharmaceuticals, Inc., the maker of Pradaxa. [read post]
25 Jul 2012, 4:03 pm by Leon Aussprung
A man from Tennessee has filed a lawsuit against Boehringer Ingelheim Pharmaceuticals, Inc., the maker of Pradaxa. [read post]
25 Jul 2012, 12:42 pm
Two more plaintiffs have come forward seeking drug injury compensation from Boehringer Ingelheim Pharmaceuticals Inc. for the harm they have suffered from taking Pradaxa. [read post]
8 Jul 2012, 9:13 pm by Patent Docs
Prism C.V. • Defendants: Roxane Laboratories, Inc.; Boehringer Ingelheim Roxane, Inc. [read post]
15 Jun 2012, 2:51 pm by bradhendrickslawfirm
Pradaxa Approved by FDA in 2010 and Investigated by 2011 In 2010, the United States Food & Drug Administration (FDA) approved Pradaxa, manufactured by Boehringer Ingelheim Pharmaceuticals, Inc., as a direct thrombin inhibitor indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. [read post]
2 May 2012, 11:11 am
According to the complaint, Boehringer Ingelheim Pharmaceuticals, Inc. concealed knowledge that Pradaxa can cause serious, life-threatening bleeds, and did not warn that Pradaxa bleeding side effects may be irreversible. [read post]